Key result
Early CGM program linked to narrowed insurance-based HbA1c disparities, flattening the disparity slope to 0.01.
Why the study?
Does early continuous glucose monitoring with programmatic support reduce disparities and improve glycemia in youth with new-onset type 1 diabetes?
Cohort
Does early continuous glucose monitoring with programmatic support reduce disparities and improve glycemia in youth with new-onset type 1 diabetes?
Early initiation of continuous glucose monitoring with programmatic support in youth with new-onset type 1 diabetes is associated with improved glycemic outcomes and attenuation of sociodemographic disparities.
OBJECTIVE: To assess in youth with type 1 diabetes (T1D) whether initiation of early continuous glucose monitoring (CGM) with programmatic support to address sociodemographic barriers is associated with reduced disparities and improved glycemia. METHODS: CGM was initiated <1 month post-diagnosis with remote monitoring and <7% hemoglobin (Hb) A1c target in youth with new-onset T1D in the Teamwork, Targets, Technology, and Tight Glycemia (4T) program. We evaluated HbA1c stratified by race and ethnicity, insurance, deprivation, and language across 3 cohorts: historical (6/2014-12/2016), pilot (7/2018-6/2020), and study 1 (6/2020-03/2022). RESULTS: At 12 months in study 1, HbA1c was lowest among non-Hispanic White (6.5% [95%CI 6.2,6.9]), low deprivation (6.5% [95%CI 6.2,6.9]), private insurance (6.6% [95%CI 6.3,7]), and English preference (6.7%[95%CI 6.4,7]). HbA1c disparities were attenuated in study 1: ethnicity slopes changed from historical (0.09 [95%CI -0.02,0.20]) to pilot (0.14[ 95%CI -0.04,0.31) to study 1 (0.08 [95%CI -0.07,0.23]). Insurance slopes improved from historical (0.20 [95%CI 0.09,0.31]) to pilot (0.12 [95%CI -0.06,0.29]) to study 1 (0.01[95%CI -0.14,0.16]). Deprivation (41.3%) and race and ethnicity (32.2%) contributed most to HbA1c variability. CONCLUSIONS: Study 1 was associated with improved glycemic outcomes and attenuation of some disparities, particularly by insurance and ethnicity, supporting 4T as an effective equity-oriented care model. Deprivation emerged as a key model-derived contributor to variability in HbA1c and may represent an important target to reduce disparities in pediatric T1D glycemia.
No takes yet. Share an insight, caveat, or question.
Addala et al. (2026) conducted a cohort in type 1 diabetes. Early continuous glucose monitoring with programmatic support (4T program) vs. Historical cohort was evaluated on HbA1c disparities by race, ethnicity, insurance, deprivation, and language. The 4T program (early CGM and support) attenuated HbA1c disparities by insurance, with the insurance slope improving from 0.20 historically to 0.01 (95% CI -0.14 to 0.16) at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: